buckel p (34 resultados)

Taschenbuch. Condición: Gut. 196 S. Innerhalb Deutschlands Versand je nach Größe/Gewicht als Großbrief bzw. Bücher- und Warensendung mit der Post oder per DHL. Rechnung mit MwSt.-Ausweis liegt jeder Lieferung bei. Sprache: Deutsch Gewicht in Gramm: 259.

Hardcover. Condición: New. No Jacket. 1st Edition. Birkhäuser Verlag (2001). New Hardcover. 9.4"x6.7". be44439.

Condición: New. In.

Condición: New. In.

Condición: New.

Condición: New.

Condición: As New. Unread book in perfect condition.

Condición: New. Presents the historical, technical and clinical aspects of recombinant protein drug discovery and development. Editor(s): Buckel, P. Series: Milestones in Drug Therapy. Num Pages: 217 pages, biography. BIC Classification: MMG; TCB; TDCW. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 14. Weight in Grams: 493. . 2001. Hardback. . . . .

Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Recombinant protein drugs are intimately associated with the impressive success story of the Biotech Industry during the past thirty years, some of them belonging to the most successful pharmaceutical products. More than thirty different proteins are available for a variety of clinical applications, over 300 proteins are presently being evaluated in clinical trials. In this new volume of the MDT series, historical, technical and clinical aspects of recombinant protein drug discovery and development are presented, covering past, present and future highlights. Leading scientists and co-founders of early Biotech companies describe technical breakthroughs and the fascinating story of pioneering discoveries, as well as the long way of translating them into products and business. Therefore, this book represents an exciting documentation of the beginning of a new era in the pharmaceutical industry. In addition, scientists from basic research, clinic and industry actively involved in new developments discuss.

Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Recombinant protein drugs are intimately associated with the impressive success story of the Biotech Industry during the past thirty years, some of them belonging to the most successful pharmaceutical products. More than thirty different proteins are available for a variety of clinical applications, over 300 proteins are presently being evaluated in clinical trials. In this new volume of the MDT series, historical, technical and clinical aspects of recombinant protein drug discovery and development are presented, covering past, present and future highlights. Leading scientists and co-founders of early Biotech companies describe technical breakthroughs and the fascinating story of pioneering discoveries, as well as the long way of translating them into products and business. Therefore, this book represents an exciting documentation of the beginning of a new era in the pharmaceutical industry. In addition, scientists from basic research, clinic and industry actively involved in new developments discuss.

Condición: gut. Recombinant Protein Drugs (Milestones in Drug Therapy) In deutscher Sprache. pages.

Condición: New. pp. 220.

Condición: New.

Condición: New. pp. 224.

Paperback. Condición: Brand New. 220 pages. 9.25x6.10x0.50 inches. In Stock.

Condición: New. Presents the historical, technical and clinical aspects of recombinant protein drug discovery and development. Editor(s): Buckel, P. Series: Milestones in Drug Therapy. Num Pages: 217 pages, biography. BIC Classification: MMG; TCB; TDCW. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 14. Weight in Grams: 493. . 2001. Hardback. . . . . Books ship from the US and Ireland.

Paperback. Condición: Like New. Like New. book.

Condición: As New. Unread book in perfect condition.

Condición: As New. Unread book in perfect condition.

Couverture souple. Condición: bon. R240120538: 1997. In-8. Broché. Bon état, Couv. convenable, Dos satisfaisant, Intérieur frais. 1056 pages - nombreuses capture d'écran noir et blanc dans le texte - CD-Rom en bon état inclus sous pochette papier en fin d'ouvrage. . . . Classification Dewey : 4-Traitement des données. Informatique.

Couverture rigide. Condición: bon. RO20181328: 1996. In-8. Relié. Bon état, Couv. convenable, Dos satisfaisant, Intérieur frais. 1057 pages - nombreux impressions ecrans en noir et blanc dans et hors texte. . . . Classification Dewey : 0-GENERALITES.

Condición: new. Questo è un articolo print on demand.

Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. With the surprising discovery of superconductivity at temperatures above 100 K, this field was not only brought into the public eye, but also stimulated research in universities, scientific institutions and industry, thus continuing the fascinating developm.

Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Recombinant protein drugs are intimately associated with the impressive success story of the Biotech Industry during the past thirty years, some of them belonging to the most successful pharmaceutical products. More than thirty different proteins are available for a variety of clinical applications, over 300 proteins are presently being evaluated in clinical trials. In this new volume of the MDT series, historical, technical and clinical aspects of recombinant protein drug discovery and development are presented, covering past, present and future highlights. Leading scientists and co-founders of early Biotech companies describe technical breakthroughs and the fascinating story of pioneering discoveries, as well as the long way of translating them into products and business. Therefore, this book represents an exciting documentation of the beginning of a new era in the pharmaceutical industry. In addition, scientists from basic research, clinic and industry actively involved in new developments discuss. 220 pp. Englisch.

Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Recombinant protein drugs are intimately associated with the impressive success story of the Biotech Industry during the past thirty years, some of them belonging to the most successful pharmaceutical products. More than thirty different proteins are availa.

Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Recombinant protein drugs are intimately associated with the impressive success story of the Biotech Industry during the past thirty years, some of them belonging to the most successful pharmaceutical products. More than thirty different proteins are availa.

Buch. Condición: Neu. Recombinant Protein Drugs | P. Buckel | Buch | x | Englisch | 2001 | Birkhäuser Basel | EAN 9783764359041 | Verantwortliche Person für die EU: Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.

Buch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Recombinant protein drugs are intimately associated with the impressivesuccess story of the Biotech Industry during the past thirty years, someof them belonging to the most successful pharmaceutical products. Morethan thirty different proteins are available for a variety of clinicalapplications, over 300 proteins are presently being evaluated inclinical trials.In this new volume of the MDT series, historical, technical and clinicalaspects of recombinant protein drug discovery and development arepresented, covering past, present and future highlights. Leadingscientists and co-founders of early Biotech companies describe technicalbreakthroughs and the fascinating story of pioneering discoveries, aswell as the long way of translating them into products and business.Therefore, this book represents an exciting documentation of thebeginning of a new era in the pharmaceutical industry. In additionscientists from basic research, clinic and industry actively involved innew developments discuss.Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 224 pp. Englisch.

Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Recombinant protein drugs are intimately associated with the impressivesuccess story of the Biotech Industry during the past thirty years, someof them belonging to the most successful pharmaceutical products. Morethan thirty different proteins are available for a variety of clinicalapplications, over 300 proteins are presently being evaluated inclinical trials.In this new volume of the MDT series, historical, technical and clinicalaspects of recombinant protein drug discovery and development arepresented, covering past, present and future highlights. Leadingscientists and co-founders of early Biotech companies describe technicalbreakthroughs and the fascinating story of pioneering discoveries, aswell as the long way of translating them into products and business.Therefore, this book represents an exciting documentation of thebeginning of a new era in the pharmaceutical industry. In additionscientists from basic research, clinic and industry actively involved innew developments discuss.Springer Nature c/o IBS, Benzstrasse 21, 48619 Heek 220 pp. Englisch.

Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Recombinant protein drugs are intimately associated with the impressive success story of the Biotech Industry during the past thirty years, some of them belonging to the most successful pharmaceutical products. More than thirty different proteins are available for a variety of clinical applications, over 300 proteins are presently being evaluated in clinical trials. In this new volume of the MDT series, historical, technical and clinical aspects of recombinant protein drug discovery and development are presented, covering past, present and future highlights. Leading scientists and co-founders of early Biotech companies describe technical breakthroughs and the fascinating story of pioneering discoveries, as well as the long way of translating them into products and business. Therefore, this book represents an exciting documentation of the beginning of a new era in the pharmaceutical industry. In addition, scientists from basic research, clinic and industry actively involved in new developments discuss. 207 pp. Englisch.